How Much Do Patients Need to Know About a Potentially Risky Treatment?

An unapproved product made from umbilical cord blood was used at a prominent New York hospital. After an F.D.A. warning came an internal complaint: Patients should have been told.

Advertisements
{ "slotId": "6845006044", "unitType": "responsive", "resize": "auto" }

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.